Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6636 USD | +3.53% | +0.55% | -11.00% |
May. 07 | Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy | CI |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
Chart calendar Traws Pharma, Inc.
Upcoming events on Traws Pharma, Inc.
Past events on Traws Pharma, Inc.
2024-04-08 12:00 pm | American Association for Cancer Research Meeting |
2024-04-02 08:30 am | Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Merger Call |
2024-03-31 | Q4 2023 Earnings Release |
2023-12-11 09:00 pm | American Society of Hematology Meeting - Poster Number: 4181 |
2023-12-07 | San Antonio Breast Cancer Conference |
2023-12-04 10:30 am | Noble Capital Markets Emerging Growth Equity Conference |
2023-11-14 04:30 pm | Q3 2023 Earnings Call |
2023-11-14 04:05 pm | Q3 2023 Earnings Release |
2023-10-12 10:00 am | European Academy of Dermatology and Venereology Conference - Session:D2T01.3 |
2023-10-06 | European MCL Network Meeting |
2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
2023-08-10 04:30 pm | Q2 2023 Earnings Call |
2023-08-10 04:05 pm | Q2 2023 Earnings Release |
2023-08-10 09:00 am | Annual General Meeting - Reconvened |
2023-07-21 09:00 am | Annual General Meeting |
2023-06-16 | International Conference on Malignant Lymphoma |
2023-06-02 | American Society of Clinical Oncology Conference |
2023-05-18 11:00 am | Ladenburg Thalmann Virtual R&D Showcase |
2023-05-15 04:30 pm | Q1 2023 Earnings Call |
2023-05-15 04:18 pm | Q1 2023 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 2,18 2,21 -1.01% | 0,23 0,20 12.86% | 0,23 0,23 -2.59% | 0,23 0,21 8.92% | 0,23 0,22 4.96% | 0,21 |
EBITDA Million USD | Released Forecast Spread | -21,7 -22,4 3.19% | -25,0 -25,3 1.26% | -16,5 -18,6 11.39% | -19,6 -19,7 0.44% | -20,3 0,00 - | -23,5 |
EBIT Million USD | Released Forecast Spread | -21,7 -21,9 1.04% | -25,0 -24,4 -2.51% | -16,5 -17,5 5.83% | -19,6 -20,0 1.82% | -20,3 -21,2 4.36% | -23,5 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -21,5 -21,7 0.84% | -25,2 -24,3 -3.32% | -16,2 -17,0 4.99% | -19,0 -19,8 4% | -18,9 -20,5 7.68% | -23,3 |
Net income Million USD | Released Forecast Spread | -21,5 -21,7 0.8% | -25,2 -24,3 -3.34% | -16,2 -17,0 4.99% | -19,0 -19,8 4% | -18,9 -20,5 7.68% | -23,3 |
EPS USD | Released Forecast Spread | -22,3 -12,1 -85.09% | -2,10 -2,05 -2.44% | -0,96 -0,92 -4.35% | -0,91 -0,93 1.62% | -0,90 -0,96 5.92% | -0,87 |
Announcement Date | 24/03/20 | 11/03/21 | 17/03/22 | 16/03/23 | 01/04/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,06 0,06 -5.88% | 0,06 0,08 -29.11% | 0,06 0,06 -0.44% | 0,06 0,07 -22.63% | 0,06 0,06 -10.4% | 0,06 0,08 -29.11% | 0,06 0,07 -17.69% | 0,06 0,07 -17.69% | 0,06 0,07 -14.28% | 0,06 | 0,06 | 0,06 | 0,06 |
EBITDA Million USD | Released Forecast Spread | -3,76 -5,90 36.29% | -4,13 -3,90 -5.87% | -4,12 -4,30 4.28% | -5,64 -4,40 -28.14% | -5,73 -5,80 1.21% | -6,13 -5,80 -5.76% | -6,20 | -5,08 -5,50 7.56% | -4,46 | ||||
EBIT Million USD | Released Forecast Spread | -3,76 -4,26 11.65% | -4,13 -4,17 0.97% | -4,12 -4,46 7.62% | -5,64 -4,62 -22.23% | -5,73 -6,29 8.85% | -6,14 -6,67 7.96% | -4,61 -6,82 32.36% | -5,09 -6,57 22.56% | -4,46 -5,51 19.06% | ||||
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,76 -4,61 18.39% | -4,12 -4,05 -1.82% | -4,02 -4,34 7.28% | -5,40 -4,51 -19.69% | -5,42 -6,06 10.57% | -5,78 -6,28 8.02% | -4,25 -6,51 34.72% | -4,74 -6,47 26.77% | -4,18 -5,21 19.64% | ||||
Net income Million USD | Released Forecast Spread | -3,76 -4,61 18.39% | -4,12 -4,05 -1.82% | -4,02 -4,34 7.28% | -5,40 -4,51 -19.69% | -5,42 -6,06 10.57% | -5,78 -6,28 8.02% | -4,25 -6,51 34.72% | -4,74 -6,47 26.77% | -4,18 -5,21 19.64% | ||||
EPS USD | Released Forecast Spread | -0,16 -0,27 40.74% | -0,20 -0,19 -6.67% | -0,19 -0,20 3.8% | -0,26 -0,21 -22.35% | -0,26 -0,28 6.31% | -0,28 -0,30 5.88% | -0,20 -0,31 36% | -0,23 -0,29 20.69% | -0,20 -0,25 21.05% | -0,23 | -0,25 | -0,28 | -0,29 |
Announcement Date | 17/03/22 | 11/05/22 | 11/08/22 | 14/11/22 | 16/03/23 | 15/05/23 | 10/08/23 | 14/11/23 | 01/04/24 | - | - | - | - |
Past sector events for Traws Pharma, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TRAW Stock
- Calendar Traws Pharma, Inc.